Salah El-Saheb

Salah El-Saheb is an experienced executive in the pharmaceutical industry, currently serving as Executive Director and Evidence Generation Leader at Genentech since July 2019. With a focus on advancing inclusive research and fostering innovative patient-centric trials, Salah leads the non-oncology portfolio, covering areas such as Neuroscience, Rare Disease, Immunology, Ophthalmology, Respiratory, and Infectious Disease. Prior to this role, Salah was Senior Director of Clinical Science at Acerta Pharma B.V. (AstraZeneca Group), where responsibilities included building a Heme center of excellence and contributing to the non-Hodgkin's lymphoma development program. Earlier positions at Genentech involved overseeing major operational initiatives for the Tecentriq lung/head and neck team, while earlier roles at Roche and Rutgers University involved study management and affiliate management. Salah holds a PharmD from Albany College of Pharmacy and Health Sciences and a Post-Doctoral Fellowship from Rutgers University, complemented by a BSc in Biology from Concordia University.